Four teams of cancer researchers two from Virginia and one each from Ohio and Massachusetts are receiving combined support from both organizations and their funding partners. These Grants bring together some of the best scientists and physicians in the U.S. to accelerate progress against this dreaded disease. The teams led by cancer researchers Theresa A. Guise, M.D. (University of Virginia Cancer Center, Charlottesville, Va.), Mark R. Parthun, Ph.D. (The Ohio State University Comprehensive Cancer Center, Columbus, Ohio), Peter O'Connell, Ph.D. (Virginia Commonwealth University Massey Cancer Center, Richmond, Va.) and Jeffrey E. Settleman, Ph.D. (Massachusetts General Hospital Cancer Center, Boston, Mass.) will each receive $600,000 for their research projects over the next three years.

"We are extremely pleased to partner with The V Foundation and others to fund these projects in translational research," said Margaret Foti, Ph.D., M.D. (h.c.), Chief Executive Officer with the AACR.

"Supporting translational research which benefits patients is fundamental to the mission of the AACR, and these grants are an integral part of that effort."

Added Nick Valvano, Chief Executive Officer of The V Foundation: "We are excited that in our first collaborative effort with the AACR, we are able to fund such talented scientists and clinicians."

Translational research is a two-way bridge that conveys new ideas and discoveries between the laboratory and the clinic. In this manner, advances in such areas as molecular genetics, regulatory proteins and cellular signaling can be applied to new diagnostic technologies and targeted treatments to help the cancer patients.

The V Foundation-AACR Grants in Translational Ca
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
17-Dec-2004